home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration
CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration
Post navigation
Previous Post
Previous
Blueprint Medicines Announces New Phase 1 Clinical Data for BLU-285 in Advanced Gastrointestinal Stromal Tumors and Plans to Pursue Expedited Development in Patients with a PDGFRα D842V Mutation
Next Post
Next
Neon Therapeutics Enters License Agreement with the Netherlands Cancer Institute for Neoantigen-based T Cell Therapeutics